Status:

COMPLETED

Propofol Patient-controlled Sedation for Endoscopic Retrograde Cholangiopancreatography

Lead Sponsor:

University Hospital, Linkoeping

Conditions:

Endoscopic Retrograde Cholangiopancreatography

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Propofol sedation with opioids is used for endoscopic retrograde cholangiopancreatography (ERCP). Combination of sedatives and opioids is associated with increased morbidity/mortality. Delivery of onl...

Eligibility Criteria

Inclusion

  • Need for ERCP
  • Able to speak and read swedish

Exclusion

  • Allergy to propofol
  • Severe cardiopulmonary disease (ASA IV)
  • Confusion or dementia

Key Trial Info

Start Date :

October 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2012

Estimated Enrollment :

281 Patients enrolled

Trial Details

Trial ID

NCT01505218

Start Date

October 1 2010

End Date

May 1 2012

Last Update

November 9 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Linköping University Hospital

Linköping, Sweden, 581 85

Propofol Patient-controlled Sedation for Endoscopic Retrograde Cholangiopancreatography | DecenTrialz